By Robin Liang, PhD in TREC
There is a continuous search for finding laboratory markers that are associated with an increased risk of venous thromboembolism (VTE). While the focus has been mainly on procoagulant pathways that form the clot, there have been relatively few studies that
examine fibrinolytic (clot-breaking) activity in relation to the risk of VTE. Continue reading